Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pangon

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Journal of Clinical Microbiology|January 1, 1987
Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndromeV Lévy-Frébault, B Pangon, A Buré, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coliG C Paul, G Gerbaud, A Bure, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1987
Bactericidal activity against Haemophilus influenzae of cerebrospinal fluid of patients given amoxicillin-clavulanic acidJ M Decazes, A Bure, M Wolff, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 30, 1999
Antimicrobial susceptibility of 471 enterococcal strains responsible for infections at 101 French hospitals. Collège de Bactériologie, Virologie, Hygiène des HôpitauxB Pangon, P Pina, L Gazagne, et al.
The Journal of Infectious Diseases|May 1, 1989
In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamaseB Pangon, C Bizet, A Buré, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1989
Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditisB Fantin, B Pangon, G Potel, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamaseF Caron, L Gutmann, A Bure, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national surveyJ-W Decousser, P Pina, F Picot, et al.
Presse Medicale (Paris, France : 1983)|August 3, 1988
[Tuberculosis in patients infected with the human immunodeficiency virus. 30 cases]C Perronne, M Zahraoui, C Leport, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1986
Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditisA Contrepois, J M Vallois, J J Garaud, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|January 1, 1987
Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndromeV Lévy-Frébault, B Pangon, A Buré, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coliG C Paul, G Gerbaud, A Bure, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1987
Bactericidal activity against Haemophilus influenzae of cerebrospinal fluid of patients given amoxicillin-clavulanic acidJ M Decazes, A Bure, M Wolff, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 30, 1999
Antimicrobial susceptibility of 471 enterococcal strains responsible for infections at 101 French hospitals. Collège de Bactériologie, Virologie, Hygiène des HôpitauxB Pangon, P Pina, L Gazagne, et al.
The Journal of Infectious Diseases|May 1, 1989
In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamaseB Pangon, C Bizet, A Buré, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1989
Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditisB Fantin, B Pangon, G Potel, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamaseF Caron, L Gutmann, A Bure, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national surveyJ-W Decousser, P Pina, F Picot, et al.
Presse Medicale (Paris, France : 1983)|August 3, 1988
[Tuberculosis in patients infected with the human immunodeficiency virus. 30 cases]C Perronne, M Zahraoui, C Leport, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1986
Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditisA Contrepois, J M Vallois, J J Garaud, et al.
Pageof 6